Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study von THIGPEN, J. Tate, BRADY, Mark F, HOMESLEY, Howard D, MALFETANO, John, DUBESHTER, Brent, BURGER, Robert A, SHU LIAO

Volltext

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma von Rose, Peter G, Nerenstone, Stacy, Brady, Mark F, Clarke-Pearson, Daniel, Olt, George, Rubin, Stephen C, Moore, David H, Small, James M

Volltext

Simultaneously Detected Endometrial and Ovarian Carcinomas— A Prospective Clinicopathologic Study of 74 Cases: A Gynecologic Oncology Group Study von Zaino, Richard, Whitney, Charles, Brady, Mark F., DeGeest, Koen, Burger, Robert A., Buller, Richard E.

Volltext

Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group S... von MUGGIA, F. M, BRALY, P. S, BRADY, M. F, SUTTON, G, NIEMANN, T. H, LENTZ, S. L, ALVAREZ, R. D, KUCERA, P. R, SMALL, J. M

Volltext

Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group von THIGPEN, J. T, BRADY, M. F, ALVAREZ, R. D, ADELSON, M. D, HOMESLEY, H. D, MANETTA, A, SOPER, J. T, GIVEN, F. T

Volltext

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer von McGuire, William P, Hoskins, William J, Brady, Mark F, Kucera, Paul R, Partridge, Edward E, Look, Katherine Y, Clarke-Pearson, Daniel L, Davidson, Martin

Volltext

Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study von THIGPEN, Tate, BRADY, Mark F, HOMESLEY, Howard D, SOPER, John T, BELL, Jeffrey

Volltext

Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data von Tierney, J F, Stewart, L A, Parmar, M K B

Volltext

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125 von RUSTIN, G. J. S, NELSTROP, A. E, MCCLEAN, P, BRADY, M. F, MCGUIRE, W. P, HOSKINS, W. J, MITCHELL, H, LAMBERT, H. E

Volltext

Phase III Trial of Paclitaxel at Two Dose Levels, the Higher Dose Accompanied by Filgrastim at Two Dose Levels in Platinum-Pretreated Epithelial Ovarian Cancer: An Intergroup Study von OMURA, George A, BRADY, Mark F, LOOK, Katherine Y, AVERETTE, Hervy E, DELMORE, James E, LONG, Harry J, WADLER, Scott, SPIEGEL, Gregory, ARBUCK, Susan G

Volltext

Gynecological cancers translational, research implementation, and harmonization: Gynecologic Cancer InterGroup consensus and still open questions von Bagnoli, M, Shi, TY, Gourley, C, Speiser, P, Reuss, A, Nijman, HW, Creutzberg, CL, Scholl, S, Negrouk, A, Brady, MF, Hasegawa, K, Oda, K, McNeish, IA, Kohn, EC, Oza, AM, MacKay, H, Millan, D, Bennett, K, Scott, C, Mezzanzanica, D

Volltext

Phase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study von MARKMAN, M, BRADY, M. F, SPIRTOS, N. M, HANJANI, P, RUBIN, S. C

Volltext

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma von Hoskins, William J., McGuire, William P., Brady, Mark F., Homesley, Howard D., Creasman, William T., Berman, Michael, Ball, Harrison, Berek, Jonathan S.

Volltext

Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study von Major, Francis J., Blessing, John A., Silverberg, Steven G., Morrow, C. Paul, Creasman, William T., Currie, John L., Yordan, Edgardo, Brady, Mark F.

Volltext

Preparation of atomically flat surfaces on silicon carbide using hydrogen etching von Ramachandran, V., Brady, M. F., Smith, A. R., Feenstra, R. M., Greve, D. W.

Volltext

Phase II Study of Paclitaxel and Valspodar (PSC 833) in Refractory Ovarian Carcinoma: A Gynecologic Oncology Group Study von FRACASSO, Paula M, BRADY, Mark F, MOORE, David H, WALKER, Joan L, ROSE, Peter G, LETVAK, Laurie, GROGAN, Thomas M, MCGUIRE, William P

Volltext

Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma—a Gynecol... von Bloss, Jeffrey D, Brady, Mark F, Liao, Shu Yuan, Rocereto, Thomas, Partridge, Edward E, Clarke-Pearson, Daniel L

Volltext

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study von MCGUIRE, W. P, HOSKINS, W. J, BRADY, M. F, HOMESLEY, H. D, CREASMAN, W. T, BERMAN, M. L, BALL, H, BEREK, J. S, WOODWARD, J

Volltext

Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study von BARNHILL, D. R, KURMAN, R. J, BRADY, M. F, OMURA, G. A, YORDAN, E, GIVEN, F. T, KUCERA, P. R, ROMAN, L. D

Volltext

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience von OMURA, G. A, BRADY, M. F, HOMESLEY, H. D, YORDAN, E, MAJOR, F. J, BUCHSBAUM, H. J, PARK, R. C

Volltext